v3.26.1
Consolidated Statements of Cash Flows - CAD ($)
$ in Thousands
 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating activities    
Net income (loss) from continuing operations $ (58,619) $ 27,050 [1]
Adjustments for non-cash items:    
Unrealized gain on changes in fair value of biological assets (116,131) (168,111) [1]
Changes in fair value of inventory and biological assets sold 138,255 131,985 [1]
Depreciation of property, plant and equipment 13,384 12,289 [1]
Amortization of intangible assets 808 315 [1]
Share-based compensation 7,293 11,524 [1]
Impairment of property, plant and equipment 2,775 696 [1]
Impairment of intangible assets and goodwill 13,186 0 [1]
Net interest accrual and accretion (1,147) 1,355 [1]
Deferred tax recovery (expense) 55 (3,152) [1]
Other gains (losses) (720) (1,463) [1]
Foreign exchange gain (loss) (1,558) (11,529) [1]
Deferred compensation amortization 3,805 3,805 [1]
Cash provided by (used in) operating activities from continuing operations before changes in non-cash working capital 1,386 4,764 [1]
Changes in non-cash working capital (9,214) 14,205 [1]
Net cash provided by (used in) operating activities from continuing operations (7,828) 18,969 [1]
Net cash used in operating activities from discontinued operations (5,683) (2,963) [1]
Net cash provided by (used in) operating activities (13,511) 16,006 [1]
Investing activities    
Purchase of short-term investments (52,213) 0 [1]
Proceeds from disposal of marketable securities 0 5,488 [1]
Purchase of property, plant and equipment and intangible assets (22,545) (15,054) [1]
Proceeds from disposal of property, plant and equipment and assets held for sale 1,096 1,981 [1]
Changes in restricted cash 818 (4,283) [1]
Cash provided by (used in) investing activities from continuing operations (72,844) (11,868) [1]
Net cash provided by (used in) investing activities from discontinued operations 235 (2,460) [1]
Net cash provided by (used in) investing activities (72,609) (14,328) [1]
Financing activities    
Net principal payments of lease liabilities (5,019) (5,240) [1]
Proceeds from issuance of shares 10,906 0 [1]
Share issuance costs (1,578) 0 [1]
Proceeds from stock option exercise 587 820 [1]
Cash provided by (used in) financing activities from continuing operations 4,896 (4,420) [1]
Net cash provided by (used in) financing activities from discontinued operations 4,865 4,304 [1]
Net cash provided by (used in) financing activities 9,761 (116) [1]
Effect of foreign exchange on cash and cash equivalents 3,128 264 [1]
Increase (decrease) in cash and cash equivalents (73,231) 1,826 [1]
Cash and cash equivalents, beginning of period [1] 137,921 136,095
Cash and cash equivalents, end of period $ 64,690 $ 137,921 [1]
[1] Adjusted for discontinued operations (Note 6).